Evidence map›Paper›PMID 33363536›Full record

ArticleFrontiers in immunology2020

Myeloid Cell CK2 Regulates Inflammation and Resistance to Bacterial Infection.

Sandy R Larson, Nikki Bortell, Alysha Illies, William J Crisler, Jennifer L Matsuda, Laurel L Lenz

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Silmitasertib, an FDA-designated orphan CK2 inhibitor, ameliorates neuropathology and motor dysfunction in a Huntington's disease mouse model.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Claudin-2 upregulation enhances intestinal permeability, immune activation, dysbiosis, and mortality in sepsis.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Review
  9. Article
  10. Protein Kinase CK2 Controls CD8Journal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Protein Kinase CK2 Regulates B Cell Development and Differentiation.Journal of immunology (Baltimore, Md. : 1950) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sandy R LarsonImmunology and Microbiology Department, University of Colorado School of Medicine, Aurora, CO, United States.
Nikki BortellImmunology and Microbiology Department, University of Colorado School of Medicine, Aurora, CO, United States.
Alysha IlliesImmunology and Microbiology Department, University of Colorado School of Medicine, Aurora, CO, United States.
William J CrislerImmunology and Microbiology Department, University of Colorado School of Medicine, Aurora, CO, United States.
Jennifer L MatsudaDepartment of Biomedical Research, National Jewish Health, Denver, CO, United States.
Laurel L LenzImmunology and Microbiology Department, University of Colorado School of Medicine, Aurora, CO, United States.
University of Colorado Denver · US

Funding

TRAINING PROGRAM IN IMMUNOLOGYT32AI007405 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Laurel L Lenz, Raul Martin Torres · 1991 to 2026
$10.5M
NK cell IL-10 production during bacterial infectionsR01AI131662 · NIAID · UNIVERSITY OF COLORADO DENVER · PI LENZ, LAUREL L · 2017 to 2021
$2.9M
IFNGR Down Regulation as a Host Target for Therapy of Infectious DiseasesR33AI102264 · NIAID · UNIVERSITY OF COLORADO DENVER · PI LENZ, LAUREL L · 2014 to 2016
$1.1M
Myeloid cell IFNGR regulation in persistent viral and secondary bacterial infectionsR21AI140499 · NIAID · UNIVERSITY OF COLORADO DENVER · PI LENZ, LAUREL L · 2018 to 2019
$420k
NIAID NIH HHS R01 AI131662NIAID NIH HHS R21 AI140499NIAID NIH HHS R33 AI102264NIAID NIH HHS T32 AI007405
6 · The paper itself

Abstract

Kinase activity plays an essential role in the regulation of immune cell defenses against pathogens. The protein kinase CK2 (formerly casein kinase II) is an evolutionarily conserved kinase with hundreds of identified substrates. CK2 is ubiquitously expressed in somatic and immune cells, but the roles of CK2 in regulation of immune cell function remain largely elusive. This reflects the essential role of CK2 in organismal development and limited prior work with conditional CK2 mutant murine models. Here, we generated mice with a conditional (floxed) allele of

Indexed as

Listeria monocytogenesAnimalsCasein Kinase IIFemaleInflammationListeriosisMaleMice, Inbred C57BLMice, KnockoutMyeloid CellsCasein Kinase IICK2immune regulationinfectioninnate immunitykinaseListeria monocytogenesmonocytemyeloid cells

Identifiers

PMID33363536
PMCPMC7752951
OpenAlexW3110779554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.